Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Marotta

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Annals of the New York Academy of Sciences|March 3, 2009
Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical: an in vitro and in vivo study F Marotta, H Yadav, S Pathak, et al.
Digestion|January 1, 1993
Duodenal bicarbonate secretion induced by human epidermal growth factor in rats is partially mediated by prostaglandinsF Marotta, D H Chui, E Fesce, et al.
Beneficial Microbes|December 10, 2015
Gut microbiota in health and disease: an overview focused on metabolic inflammationR Nagpal, M Kumar, A K Yadav, et al.
Minerva Gastroenterologica E Dietologica|May 1, 2014
Irritable bowel syndrome: new findings in pathophysiological and therapeutic fieldR Catanzaro, S Occhipinti, F Calabrese, et al.
Panminerva Medica|November 13, 2014
The gut microbiota and its correlations with the central nervous system disordersR Catanzaro, M Anzalone, F Calabrese, et al.
Annals of the New York Academy of Sciences|January 31, 2007
Anti-inflammatory and neuroprotective effect of a phytoestrogen compound on rat microgliaF Marotta, G S Mao, T Liu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2004
Endotoxinemia and benzodiazepine-like substances in compensated cirrhotic patients: a randomized study comparing the effect of rifaximine alone and in association with a symbiotic preparationJ. Lighthouse, Y. Naito, A. Helmy, et al.
Giornale Di Clinica Medica|March 1, 1990
[Oral galactose tolerance test in the study of glucose metabolism disorders in patients with liver disease]F Marotta, K Hayakawa, P Morello, et al.
The American Journal of Medicine|June 9, 1989
A maintenance regimen of sucralfate 2 g at night for reduced relapse rate in duodenal ulcer disease. A one-year follow-up studyI N Marks, A H Girdwood, K A Newton, et al.
Chinese Journal of Digestive Diseases|May 21, 2005
In view of an optimal gut antifungal therapeutic strategy: an in vitro susceptibility and toxicity study testing a novel phyto-compoundYussef Metugriachuk, Olivia Kuroi, Kanok Pavasuthipaisit, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Annals of the New York Academy of Sciences|March 3, 2009
Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical: an in vitro and in vivo study F Marotta, H Yadav, S Pathak, et al.
Digestion|January 1, 1993
Duodenal bicarbonate secretion induced by human epidermal growth factor in rats is partially mediated by prostaglandinsF Marotta, D H Chui, E Fesce, et al.
Beneficial Microbes|December 10, 2015
Gut microbiota in health and disease: an overview focused on metabolic inflammationR Nagpal, M Kumar, A K Yadav, et al.
Minerva Gastroenterologica E Dietologica|May 1, 2014
Irritable bowel syndrome: new findings in pathophysiological and therapeutic fieldR Catanzaro, S Occhipinti, F Calabrese, et al.
Panminerva Medica|November 13, 2014
The gut microbiota and its correlations with the central nervous system disordersR Catanzaro, M Anzalone, F Calabrese, et al.
Annals of the New York Academy of Sciences|January 31, 2007
Anti-inflammatory and neuroprotective effect of a phytoestrogen compound on rat microgliaF Marotta, G S Mao, T Liu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2004
Endotoxinemia and benzodiazepine-like substances in compensated cirrhotic patients: a randomized study comparing the effect of rifaximine alone and in association with a symbiotic preparationJ. Lighthouse, Y. Naito, A. Helmy, et al.
Giornale Di Clinica Medica|March 1, 1990
[Oral galactose tolerance test in the study of glucose metabolism disorders in patients with liver disease]F Marotta, K Hayakawa, P Morello, et al.
The American Journal of Medicine|June 9, 1989
A maintenance regimen of sucralfate 2 g at night for reduced relapse rate in duodenal ulcer disease. A one-year follow-up studyI N Marks, A H Girdwood, K A Newton, et al.
Chinese Journal of Digestive Diseases|May 21, 2005
In view of an optimal gut antifungal therapeutic strategy: an in vitro susceptibility and toxicity study testing a novel phyto-compoundYussef Metugriachuk, Olivia Kuroi, Kanok Pavasuthipaisit, et al.
Pageof 14